Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1987 Dec;58(6):659–662. doi: 10.1136/hrt.58.6.659

A genetic marker for rheumatic heart disease.

C N Rajapakse 1, K Halim 1, I Al-Orainey 1, M Al-Nozha 1, A K Al-Aska 1
PMCID: PMC1277319  PMID: 3501302

Abstract

The frequency of antigen types (A, B, C, and DR) in an unselected group of 25 patients with chronic rheumatic heart disease and an unselected group of 15 patients with acute rheumatic fever was compared with that in a group of 100 healthy volunteers. All patients and controls were Arabs of Saudi origin. Only the frequency of HLA-DR4 was significantly different in the controls and the patient groups--controls 12%, chronic rheumatic heart disease 72%, acute rheumatic fever 53%, both patient groups together 65% (relative risk 13.6 with 95% confidence interval 10.5-16.7). Eighty three per cent of 12 patients with mitral stenosis and 70% of seven with aortic incompetence had HLA-DR4 antigen. In 17 non-Saudi Arab patients who had acute rheumatic fever or chronic rheumatic heart disease, the frequency of HLA-DR4 was identical (65%) to that in Saudi patients. These findings may have implications for the pathogenesis of rheumatic fever and rheumatic heart disease.

Full text

PDF
659

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayoub E. M. The search for host determinants of susceptibility to rheumatic fever: the missing link. T. Duckett Jones Memorial Lecture. Circulation. 1984 Jan;69(1):197–201. doi: 10.1161/01.cir.69.1.197. [DOI] [PubMed] [Google Scholar]
  2. Caughey D. E., Douglas R., Wilson W., Hassall I. B. HL-A antigens in Europeans and Maoris with rheumatic fever and rheumatic heart disease. J Rheumatol. 1975 Sep;2(3):319–322. [PubMed] [Google Scholar]
  3. Falk J. A., Fleischman J. L., Zabriskie J. B., Falk R. E. A study of HL-A antigen phenotype in rheumatic fever and rheumatic heart disease patients. Tissue Antigens. 1973;3(3):173–178. doi: 10.1111/j.1399-0039.1973.tb00991.x. [DOI] [PubMed] [Google Scholar]
  4. JONES CRITERIA (modified) for guidance in the diagnosis of rheumatic fever; report of the Committee on Standards and Criteria for programs of care. Circulation. 1956 Apr;13(4):617–620. doi: 10.1161/01.cir.13.4.617. [DOI] [PubMed] [Google Scholar]
  5. Jhinghan B., Mehra N. K., Reddy K. S., Taneja V., Vaidya M. C., Bhatia M. L. HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease. Tissue Antigens. 1986 Mar;27(3):172–178. doi: 10.1111/j.1399-0039.1986.tb01517.x. [DOI] [PubMed] [Google Scholar]
  6. Layrisse Z., Rodríguez-Iturbe B., García-Ramírez R., Rodríguez A., Tiwari J. Family studies of the HLA system in acute post-streptococcal glomerulonephritis. Hum Immunol. 1983 Jul;7(3):177–185. doi: 10.1016/s0198-8859(83)80005-6. [DOI] [PubMed] [Google Scholar]
  7. Ottenhoff T. H., Torres P., de las Aguas J. T., Fernandez R., van Eden W., de Vries R. R., Stanford J. L. Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis? Lancet. 1986 Aug 9;2(8502):310–313. doi: 10.1016/s0140-6736(86)90004-8. [DOI] [PubMed] [Google Scholar]
  8. Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. doi: 10.1136/bmj.2.6148.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Patarroyo M. E., Winchester R. J., Vejerano A., Gibofsky A., Chalem F., Zabriskie J. B., Kunkel H. G. Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature. 1979 Mar 8;278(5700):173–174. doi: 10.1038/278173a0. [DOI] [PubMed] [Google Scholar]
  10. Solinger A. M., Bhatnagar R., Stobo J. D. Cellular, molecular, and genetic characteristics of T cell reactivity to collagen in man. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3877–3881. doi: 10.1073/pnas.78.6.3877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Svejgaard A., Platz P., Ryder L. P., Nielsen L. S., Thomsen M. HL-A and disease associations--a survey. Transplant Rev. 1975;22:3–43. doi: 10.1111/j.1600-065x.1975.tb01550.x. [DOI] [PubMed] [Google Scholar]
  12. TERASAKI P. I., MCCLELLAND J. D. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]
  13. Tiwari J. L., Hodge S. E., Terasaki P. I., Spence M. A. HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet. 1980 Jan;32(1):103–111. [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES